Skip to main content

MoneyWorks4Me

Lupin informs about press release

25 Aug 2022 Evaluate
Lupin has informed that it enclosed a Press Release as regards the Company having entered into an exclusive licensing agreement with l'rom Group Co, a leading pharmaceutical company in Japan for Denosumab bioslmilar for Japan.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..